BobcatBio

Research Services • Derry, Pennsylvania, United States • 1-10 Employees

Company overview

Headquarters	1214 Research Boulevard, Suite 2010, Hummelstown, PA 17036, US
Websites	bobcatbio.com sirpantimmunotx.com
Employees	1-10
Socials

Key Contact at BobcatBio

Steven Ruck

Director, Process Development

BobcatBio Email Formats

BobcatBio uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@bobcatbio.com), used 66.7% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@bobcatbio.com	66.7%
{first initial}{last name}	jdoe@bobcatbio.com	33.3%

About BobcatBio

BobcatBio is spearheading the development of macrophage-based cell therapies for the treatment of solid tumors. Leveraging our deep understanding of the biology of myeloid cells—the cells that drive immune responses—BobcatBio engineers specially-equipped macrophages from a patient’s own blood cells without any genetic modifications and then provides those cells back to the patient. In pre-clinical studies, this approach has been shown to generate polyclonal tumor neo-antigen-specific killer T cell responses as well as polyclonal tumor neo-antigen-specific antibody responses, leading to complete resolution of treated tumors. This also yields an adaptive immune response that is elaborated in space (targeting metastatic lesions) and time (providing long-term immunity to prevent recurrence). In addition, because this therapeutic approach does not target specific singular tumor-associated antigens, BobcatBio technology provides a highly modular platform that is applicable across many solid tumor types, without requiring pre-identification of target tumor antigens in the patient.

BobcatBio revenue & valuation

Annual revenue	$3,000,000
Revenue per employee	$300,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$9,600,000
Total funding	$6,200,000